Show simple item record

dc.contributor.authorCarroll, CBen
dc.contributor.authorWyse, RKHen
dc.date.accessioned2017-11-21T10:57:22Z
dc.date.available2017-11-21T10:57:22Z
dc.date.issued2017-10-13en
dc.identifier.issn1877-7171en
dc.identifier.urihttp://hdl.handle.net/10026.1/10239
dc.language.isoenen
dc.publisherIOS Pressen
dc.titleSimvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progressen
dc.typeJournal Article
plymouth.journalJournal of Parkinson's Diseaseen
dc.identifier.doi10.3233/JPD-171203en
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CCT&PS
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dcterms.dateAccepted2017-10-07en
dc.rights.embargoperiodNot knownen
rioxxterms.versionofrecord10.3233/JPD-171203en
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2017-10-13en
rioxxterms.typeJournal Article/Reviewen


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
@mire NV